CompaniesCapella Bioscience

Capella Bioscience

defunct

About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

286

By Phase

PHASE1: 1NA: 2

By Status

TERMINATED: 1UNKNOWN: 1COMPLETED: 1

Clinical Trials Pipeline3 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2020

2021

2022

2023

2024

2025

Today

Hover over trial bars to see details

Recent Trials

NCT05323110Lead Sponsor

Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers

PHASE1Terminated

56 participants

Started: Apr 14, 2022 · Completed: Aug 22, 2023

NCT05375630Collaborator

Vitamin K2 and Muscle Weakness in Type 2 Diabetes

150 participants

Started: Mar 21, 2022 · Completed: Oct 31, 2024

NCT04676958Collaborator

viTAmin K2 and rEcOVery From ExeRcise

80 participants

Started: Apr 1, 2021 · Completed: Jul 1, 2023